| Predicate |
Object |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2002-444
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2430-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2400-06 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-3683
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-3687
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-3817
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-3834
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-3612
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-3658
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-3856
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-3895
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-44 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| filingDate |
2001-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2003-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2003530364-A |
| titleOfInvention |
Methods and compositions for treating intervertebral disc degeneration |
| abstract |
(57) Abstract. Fluid matrices containing remodelable crosslinked collagen from donor vertebrates are useful in vivo to regenerate the fluid lubricating function of damaged discs. The matrix is injectable and can contain cells and a plurality of purified cell growth factors. The matrix enhances cell growth and proteoglycan synthesis to promote natural tissue regeneration. The collagen in the matrix is cross-linked using a photooxidation catalytic reaction and visible light, and the purified cell growth factor is preferably at least partially derived from bone. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005107827-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111867645-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111867645-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8629122-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-6712740-B1 |
| priorityDate |
2000-04-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |